We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+6.25%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.59B
AUM Growth
+$192M
(+8%)
Cap. Flow
+$86M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
20.43%
Holding
1,510
New
76
Increased
812
Reduced
562
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$9.73M |
| 2 |
JPMorgan Chase
JPM
|
+$9.22M |
| 3 |
DuPont de Nemours
DD
|
+$7.56M |
| 4 |
Bank of America
BAC
|
+$7.18M |
| 5 |
Wells Fargo
WFC
|
+$6.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$6.94M |
| 2 |
Amgen
AMGN
|
+$6.3M |
| 3 |
Johnson & Johnson
JNJ
|
+$4.79M |
| 4 |
Gilead Sciences
GILD
|
+$4.66M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
+$4.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 19.18% |
| 3 | Financials | 11.37% |
| 4 | Communication Services | 10.09% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOC
1376
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $200K | 0.01% |
11,123
-2,016
| -15% | -$36.2K |
|
|
CALY
1377
Callaway Golf Company
CALY
$3.26B
| $197K | 0.01% |
14,173
+97
| +0.7% | +$1.39K |
|
1378
Rithm Capital
RITM
$5.09B
| $197K | 0.01% |
11,020
-4,653
| -30% | -$81.9K |
|
1379
CareTrust REIT
CTRE
$10.2B
| $194K | 0.01% |
+11,586
| New | +$214K |
|
1380
OR Royalties Inc
OR
$5.47B
| $193K | 0.01% |
16,675
-252
| -1% | -$3.06K |
|
|
CHK
1381
DELISTED
Chesapeake Energy Corporation
CHK
| $193K | 0.01% |
244
+2
| +0.8% | +$1.56K |
|
1382
Element Solutions
ESI
$9.12B
| $192K | 0.01% |
+19,386
| New | +$201K |
|
1383
MiMedx Group
MDXG
$626M
| $191K | 0.01% |
15,119
+1,867
| +14% | +$22.8K |
|
1384
Abercrombie & Fitch
ANF
$4.17B
| $189K | 0.01% |
10,872
-1,352
| -11% | -$20.5K |
|
|
BRKL
1385
DELISTED
Brookline Bancorp
BRKL
| $189K | 0.01% |
12,024
+662
| +6% | +$10.3K |
|
1386
SiriusPoint
SPNT
$2.98B
| $187K | 0.01% |
12,793
+907
| +8% | +$14.6K |
|
1387
Tenet Healthcare
THC
$20.1B
| $187K | 0.01% |
12,348
-283
| -2% | -$3.98K |
|
|
CBL
1388
DELISTED
CBL& Associates Properties, Inc.
CBL
| $186K | 0.01% |
32,838
-3,855
| -11% | -$25.8K |
|
|
DBD
1389
DELISTED
Diebold Nixdorf Incorporated
DBD
| $184K | 0.01% |
11,264
+226
| +2% | +$4.37K |
|
|
FSP
1390
Franklin Street Properties
FSP
$44.8M
| $181K | 0.01% |
16,812
+398
| +2% | +$4.18K |
|
|
RPT
1391
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $180K | 0.01% |
12,253
+1,023
| +9% | +$14.2K |
|
1392
DNOW Inc
DNOW
$2.63B
| $178K | 0.01% |
16,162
+1,197
| +8% | +$13.7K |
|
|
CHS
1393
DELISTED
Chicos FAS, Inc.
CHS
| $177K | 0.01% |
20,043
+313
| +2% | +$2.6K |
|
|
NE
1394
DELISTED
Noble Corporation
NE
| $175K | 0.01% |
38,709
-4,695
| -11% | -$19.5K |
|
1395
Knowles
KN
$3.22B
| $174K | 0.01% |
11,837
+522
| +5% | +$8.16K |
|
|
JCP
1396
DELISTED
J.C. Penney Company, Inc.
JCP
| $173K | 0.01% |
54,768
-4,411
| -7% | -$14.2K |
|
|
OCLR
1397
DELISTED
Oclaro Inc.
OCLR
| $173K | 0.01% |
25,638
+4,084
| +19% | +$30.2K |
|
1398
Helix Energy Solutions
HLX
$1.46B
| $167K | 0.01% |
22,203
+109
| +0.5% | +$771 |
|
|
HZNP
1399
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $164K | 0.01% |
11,230
-1,625
| -13% | -$22.8K |
|
|
BEL
1400
DELISTED
Belmond Ltd.
BEL
| $164K | 0.01% |
13,383
+2,267
| +20% | +$29K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Profund Advisors held 1,510 positions worth $2.59B, up 8% from $2.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Profund Advisors deployed $86M of net new capital in Q4 2017, opening 76 new positions and adding to 812 existing holdings. Its largest new stake was New Relic, Inc.: 35,199 shares worth $2.03M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $6.94M trimmed.
- Profund Advisors's largest Q4 2017 buy was New Relic, Inc.: 35,199 shares worth $2.03M.
- Profund Advisors added most to Intel in Q4 2017, an estimated $9.73M increase.
- Profund Advisors's biggest Q4 2017 reduction was AbbVie, cutting an estimated $6.94M.
- Profund Advisors fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $4.07M.
- Profund Advisors's ten largest holdings make up 20% of its $2.59B portfolio in Q4 2017.
- Profund Advisors opened 76 new positions and closed 56 in Q4 2017.
- Profund Advisors's portfolio value rose 8% quarter-over-quarter to $2.59B.
Based on Profund Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.